uremic pruritus Archivi

Protected: New Frontiers in the Treatment of Chronic Kidney Disease-associated Pruritus: A Case of Hemoperfusion with HA130

Posted on Friday April 17th, 2026

Paolo Sipari

Paolo Sipari¹, Luca Piscitani^1,2, Marilena Tunno¹

1 Nephrology and Dialysis Unit, Department of Medicine, San Salvatore Hospital, Via Lorenzo Natali n°1, 67100 L'Aquila, Italy
2 Department of Clinical Medicine, Public Health, Life and Environmental Sciences, University of L'Aquila, Via Vetoio, 67100 L’Aquila, Italy

Corresponding author:
Paolo Sipari
U.O.S.D. Nefrologia e Dialisi, Presidio Ospedaliero San Salvatore
Via Lorenzo Natali n°1
67100, L’Aquila (AQ), Italia
Tel. 0862-368745
Cell. 340-9690096
E-mail: psipari@asl1abruzzo.it

Abstract

Chronic kidney disease-associated pruritus (CKD-aP) has a high incidence in patients with end-stage chronic kidney disease on dialysis and significantly affects the quality of life of hemodialysis patients. The pathogenesis is multifactorial and still under investigation. Due to its clinical impact and its association with increased mortality, it cannot be considered merely a symptom. New drugs and treatments have been developed. We report our experience with a patient whom we had the opportunity to treat with hemoperfusion using an HA130 cartridge.

Keywords: CKD-aP, hemoperfusion, uremic pruritus, HDF